Outcomes of extended donor lung recipients after lung transplantation

Transplantation

Volumn 79, Issue 3, 2005, Pages 310-316

  Kawut, Steven M ^a,b,c   Reyentovich, Alexander ^a   Wilt, Jessie S ^a   Anzeck, Roberto ^a   Lederer, David J ^a   O'Shea, Mitchell K ^a   Sonett, Joshua R ^a   Arcasoy, Selim M ^a  

^a Columbia University ^*  (United States)

^b Div Pulmon Allerg/Critical C M ^*  (United States)

^c Pulmonary Division   (United States)

Author keywords

Clinical transplantation; Donation; Donor; Lung; Lung transplantation; Organ banking and procurement; Organ procurement; Preservation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; GANCICLOVIR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FUTUROLOGY; GRAFT REJECTION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE; LUNG FUNCTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORGAN DONOR; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL TIME;

ADULT; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; LENGTH OF STAY; LUNG TRANSPLANTATION; MALE; MEDICAL RECORDS; MIDDLE AGED; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SMOKING; SURVIVAL ANALYSIS; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES;

EID: 14544277231     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000149504.53710.AE     Document Type: Article

References (26)

1. HHS/HRSA/SPB/DOT; UNOS; URREA. 2003 OPTN/SRTR annual report: transplant data 1993-2002, Chapter 3. Available at: www.ustransplant.org. Accessed July 15, 2004.
2. Hertz MI, Taylor DO, Trulock EP, et al. The registry of the international society for heart and lung transplantation: nineteenth official report-2002. J Heart Lung Transplant 2002; 21(9): 950.
3. Orens JB, Boehler A, de Perrot M, et al. A review of lung transplant donor acceptability criteria. J Heart Lung Transplant 2003; 22(11): 1183.
4. Bhorade SM, Vigneswaran W, McCabe MA, et al. Liberalization of donor criteria may expand the donor pool without adverse consequence in lung transplantation. J Heart Lung Transplant 2000; 19(12): 1199.
5. Whiting D, Banerji A, Ross D, et al. Liberalization of donor criteria in lung transplantation. Am Surg 2003; 69(10): 909.
6. Izbicki G, Shitrit D, Aravot D, et al. The effect of donor age on survival after lung transplantation. Isr Med Assoc J 2002; 4(6): 415.
7. Weill D, Dey GC, Hicks RA, et al. A positive donor gram stain does not predict outcome following lung transplantation. J Heart Lung Transplant 2002; 21(5): 555.
8. Weill D. Donor criteria in lung transplantation: an issue revisited. Chest 2002; 121(6): 2029.
9. Sundaresan S, Semenkovich J, Ochoa L, et al. Successful outcome of lung transplantation is not compromised by the use of marginal donor lungs. J Thorac Cardiovasc Surg 1995; 109(6): 1075.
10. Fisher AJ, Donnelly SC, Pritchard G, et al. Objective assessment of criteria for selection of donor lungs suitable for transplantation. Thorax 2004; 59(5): 434.
11. Ware LB, Wang Y, Fang X, et al. Assessment of lungs rejected for transplantation and implications for donor selection. Lancet 2002; 360(9333): 619.
12. Schoenfeld DA, Bernard GR. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med 2002; 30(8): 1772.
13. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004; 291(14): 1753.
14. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288(7): 862.
15. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003; 167(2): 211.
16. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166(1): 111.
17. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152(3): 1107.
18. Cox DR. Regression models and life tables (with discussion). J R Stat Soc 1972; 34: 187.
19. Sundaresan S, Trachiotis GD, Aoe M, et al. Donor lung procurement: assessment and operative technique. Ann Thorac Surg 1993; 56(6): 1409.
20. Pierre AF, Sekine Y, Hutcheon MA, et al. Marginal donor lungs: a reassessment. J Thorac Cardiovasc Surg 2002; 123(3): 421.
21. Pierre AF, Sekine Y, Hutcheon M, et al. Evaluation of extended donor and recipient criteria for lung transplantation. J Heart Lung Transplant 2001; 20(2): 256.
22. Gabbay E, Williams TJ, Griffiths AP, et al. Maximizing the utilization of donor organs offered for lung transplantation. Am J Respir Crit Care Med 1999; 160(1): 265.
23. Novick RJ, Bennett LE, Meyer DM, et al. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant 1999; 18(5): 425.
24. Meyer DM, Bennett LE, Novick RJ, et al. Effect of donor age and ischemic time on intermediate survival and morbidity after lung transplantation. Chest 2000; 118(5): 1255.
25. Nakagawa M, Tanaka H, Tsukuma H, et al. Relationship between the duration of the preoperative smoke-free period and the incidence of postoperative pulmonary complications after pulmonary surgery. Chest 2001; 120(3): 705.
26. Dales RE, Dionne G, Leech JA, et al. Preoperative prediction of pulmonary complications following thoracic surgery. Chest 1993; 104(1): 155.